Skip to main content
 
Print Page    E-mail Page    RSS    E-mail Alerts    Tearsheet 

SEC Filings

Form S-3
SERES THERAPEUTICS, INC. filed this Form S-3 on 03/16/2017
Document Outline
Entire Document (738.5 KB)
Subdocument 1 - S-3 - FORM S-3
Page 1 - As filed with the Securities and Exchange Commission on March 16, 2017
Page 2 - CALCULATION OF REGISTRATION FEE
Page 3 - The information in this prospectus is not complete and may be changed. These securities may not be s
Page 4 - TABLE OF CONTENTS
Page 5 - ABOUT THIS PROSPECTUS
Page 6 - Incorporation by Reference
Page 7 - THE COMPANY
Page 8 - RISK FACTORS
Page 9 - Common Stock
Page 10 - Options and Restricted Stock Units
Page 11 - Undesignated Preferred Stock
Page 12 - Choice of Forum.
Page 13 - N/A
Page 14 - Transfer and Exchange
Page 15 - Global Debt Securities and Book-Entry System
Page 16 - N/A
Page 17 - Modification and Waiver
Page 18 - Defeasance of Debt Securities and Certain Covenants in Certain Circumstances
Page 19 - Defeasance of Certain Covenants
Page 20 - DESCRIPTION OF WARRANTS
Page 21 - DESCRIPTION OF UNITS
Page 22 - N/A
Page 23 - N/A
Page 24 - PLAN OF DISTRIBUTION
Page 25 - N/A
Page 26 - LEGAL MATTERS
Page 27 - PART II
Page 28 - Exhibits
Page 29 - provided
Page 30 - bona fide
Page 31 - SIGNATURES
Page 32 - N/A
Page 33 - EXHIBIT INDEX
Subdocument 2 - EX-4.2 - EX-4.2
Page 1 - Exhibit 4.2
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - N/A
Page 5 - SERES THERAPEUTICS, INC.
Page 6 - Company
Page 7 - Corporate Trust Office
Page 8 - Indenture
Page 9 - Subsidiary
Page 10 - Incorporation by Reference of Trust Indenture Act
Page 11 - Establishment of Terms of Series of Securities
Page 12 - N/A
Page 13 - Execution and Authentication
Page 14 - Registrar and Paying Agent
Page 15 - Registrar
Page 16 - Mutilated, Destroyed, Lost and Stolen Securities
Page 17 - Outstanding Securities
Page 18 - Cancellation
Page 19 - Legends
Page 20 - CUSIP Numbers
Page 21 - Notice of Redemption
Page 22 - Effect of Notice of Redemption
Page 23 - Compliance Certificate
Page 24 - Successor Corporation Substituted
Page 25 - Bankruptcy Law
Page 26 - Collection of Indebtedness and Suits for Enforcement by Trustee
Page 27 - Trustee May File Proofs of Claim
Page 28 - Application of Money Collected
Page 29 - Unconditional Right of Holders to Receive Principal and Interest
Page 30 - Waiver of Past Defaults
Page 31 - Duties of Trustee
Page 32 - Rights of Trustee
Page 33 - Individual Rights of Trustee
Page 34 - Trustee s Disclaimer
Page 35 - Replacement of Trustee
Page 36 - Successor Trustee by Merger, Etc
Page 37 - N/A
Page 38 - Application of Trust Funds; Indemnification
Page 39 - N/A
Page 40 - Covenant Defeasance
Page 41 - Repayment to Company
Page 42 - With Consent of Holders
Page 43 - Limitations
Page 44 - Notation on or Exchange of Securities
Page 45 - Notices
Page 46 - Communication by Holders with Other Holders
Page 47 - Rules by Trustee and Agents
Page 48 - No Adverse Interpretation of Other Agreements
Page 49 - Judgment Currency
Page 50 - U.S.A. Patriot Act
Page 51 - provided
Page 52 - N/A
Subdocument 3 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - March 16, 2017
Page 3 - March 16, 2017
Page 4 - March 16, 2017
Subdocument 4 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Subdocument 5 - EX-23.2 - EX-23.2
Page 1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Subdocument 6 - EX-25.1 - EX-25.1
Page 1 - Exhibit 25.1
Page 2 - N/A
Page 3 - SIGNATURE
Page 4 - EXHIBIT 1
Page 5 - ARTICLES OF ASSOCIATION
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - EXHIBIT 4
Page 13 - AMENDED AND RESTATED BYLAWS
Page 14 - Section
Page 15 - ARTICLE II
Page 16 - Section
Page 17 - Section
Page 18 - ARTICLE IV
Page 19 - ARTICLE V
Page 20 - ARTICLE VII
Page 21 - Section
Page 22 - N/A
Page 23 - ARTICLE IX
Page 24 - EXHIBIT 6
Page 25 - EXHIBIT 7